Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
Circulation|June 17, 2004
New risk factors for atherosclerosis and patient risk assessmentJean-Charles Fruchart, Melchior C Nierman, Erik S G Stroes, et al.
The Journal of Pharmacy and Pharmacology|November 27, 2004
Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cellsFrançoise Martin-Nizard, Sevser Sahpaz, Abdelmejid Kandoussi, et al.
Microbiology (Reading, England)|June 8, 2001
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populationsPatrick Duriez, Olivier Clermont, Stéphane Bonacorsi, et al.
Journal of Pineal Research|April 19, 2007
Quantification of the water/lipid affinity of melatonin and a pinoline derivative in lipid modelsJamila Mekhloufi, Heidi Vitrac, Saïd Yous, et al.
Current Drug Targets|March 22, 2013
PPARs: a potential target for a disease-modifying strategy in strokeThavarak Ouk, Camille Potey, Sophie Gautier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 8, 2003
Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic toleranceMichèle Bastide, Patrick Gelé, Olivier Pétrault, et al.
Fundamental & Clinical Pharmacology|May 25, 2013
PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental strokeThavarak Ouk, Camille Potey, Maud Laprais, et al.
Pageof 6